Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriele De Maio

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|March 18, 2025
Role of body mass index as a predictor of dupilumab efficacy in patients with severe chronic rhinosinusitis with nasal polypsLetizia Nitro, Eugenio De Corso, Marco Borin, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|December 29, 2023
Temporal trends of blood eosinophilia in severe uncontrolled CRSwNP treated with dupilumab: a real-life studyEugenio De Corso, Claudio Montuori, Silvia Baroni, et al.
International Forum of Allergy & Rhinology|January 24, 2024
Correlation between inflammatory biomarkers and disease control in chronic rhinosinusitis with nasal polypsEugenio De Corso, Silvia Baroni, Stefano Settimi, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|May 7, 2024
Comparative real-world outcomes of dupilumab versus endoscopic sinus surgery in the treatment of severe CRSwNP patientsEugenio De Corso, Davide Paolo Porru, Marco Corbò, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2026
Structural features of the hippocampus covary with memory-guided attention depending on the side of hippocampal sclerosisGerardo Salvato, Gabriele De Maio, Claudio Bertolotti, et al.
Journal of Personalized Medicine|September 28, 2024
Sinonasal Outcomes Obtained after 2 Years of Treatment with Benralizumab in Patients with Severe Eosinophilic Asthma and CRSwNP: A "Real-Life" Observational StudyEugenio De Corso, Dario Antonio Mele, Angela Rizzi, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|November 19, 2025
Influence of Multiple Prior Endoscopic Sinus Surgeries on Dupilumab Efficacy Including Smell Function in the DUPIREAL PopulationEugenio De Corso, Claudio Montuori, Elena Cantone, et al.
Allergy|August 30, 2025
Two-Year Turning Point With Dupilumab in CRSwNP: Control, Remission, and Tapering DosageEugenio De Corso, Claudio Montuori, Carlotta Pipolo, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Acta Otorhinolaryngologica Italica : Organo Ufficiale Della Societa Italiana Di Otorinolaringologia E Chirurgia Cervico-Facciale|March 18, 2025
Role of body mass index as a predictor of dupilumab efficacy in patients with severe chronic rhinosinusitis with nasal polypsLetizia Nitro, Eugenio De Corso, Marco Borin, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|December 29, 2023
Temporal trends of blood eosinophilia in severe uncontrolled CRSwNP treated with dupilumab: a real-life studyEugenio De Corso, Claudio Montuori, Silvia Baroni, et al.
International Forum of Allergy & Rhinology|January 24, 2024
Correlation between inflammatory biomarkers and disease control in chronic rhinosinusitis with nasal polypsEugenio De Corso, Silvia Baroni, Stefano Settimi, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|May 7, 2024
Comparative real-world outcomes of dupilumab versus endoscopic sinus surgery in the treatment of severe CRSwNP patientsEugenio De Corso, Davide Paolo Porru, Marco Corbò, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2026
Structural features of the hippocampus covary with memory-guided attention depending on the side of hippocampal sclerosisGerardo Salvato, Gabriele De Maio, Claudio Bertolotti, et al.
Journal of Personalized Medicine|September 28, 2024
Sinonasal Outcomes Obtained after 2 Years of Treatment with Benralizumab in Patients with Severe Eosinophilic Asthma and CRSwNP: A "Real-Life" Observational StudyEugenio De Corso, Dario Antonio Mele, Angela Rizzi, et al.
Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery|November 19, 2025
Influence of Multiple Prior Endoscopic Sinus Surgeries on Dupilumab Efficacy Including Smell Function in the DUPIREAL PopulationEugenio De Corso, Claudio Montuori, Elena Cantone, et al.
Allergy|August 30, 2025
Two-Year Turning Point With Dupilumab in CRSwNP: Control, Remission, and Tapering DosageEugenio De Corso, Claudio Montuori, Carlotta Pipolo, et al.
Pageof 2